GleamWall
中文EN

IMNM Immunome Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1472012 · Fiscal year ends 12/31

Financial factors as of 2026-03-31 (2026Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY-63.3%
TTM net income YoY-9.5%
TTM EPS YoY20.6%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-5,947.9%
Net margin-5,593.8%
FCF margin-5,118.9%
EBITDA margin-5,886.7%

Returns

ROE-50.1%
ROA-46.7%
ROIC (approx.)-679.8%
Asset turnover0.01x

Leverage & solvency

Liabilities / assets5.0%
Debt / equity0.00x
Current ratio21.68x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.87x
Accruals ratio-5.8%
Payout ratio—
Capex / revenue224.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$6.94M$9.04M
R&D expense$177.29M$129.54M
SG&A expense$43.77M$32.95M
Operating income-$224.11M-$305.80M
Income tax$0$0
Net income-$212.39M-$292.96M
EBITDA-$221.65M-$304.23M
EPS (basic)-2.43-5.00
EPS (diluted)-2.43-5.00
Weighted avg. shares (diluted)87.35M58.64M
Banking
Net interest income$11.72M$12.84M
Balance sheet
Cash & equivalents$653.48M$143.45M
Short-term investments$0$73.95M
Current assets$660.78M$221.34M
PP&E, net$14.64M$10.11M
Total assets$683.19M$240.24M
Current liabilities$44.99M$54.31M
Total liabilities$48.84M$59.08M
Shareholders' equity$634.34M$181.16M
Shares outstanding113.13M64.46M
Cash flow statement
Operating cash flow-$190.92M-$110.79M
Capital expenditure$9.69M$7.17M
Free cash flow-$200.60M-$117.97M
Investing cash flow$60.80M-$85.06M
Financing cash flow$640.36M$240.53M
Depreciation & amortization$2.47M$1.57M
Stock-based compensation$25.69M$15.75M

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.